More tools:Markets·Screener·Research Chat

Ventas, Inc. (VTR) Financial Statements

Ventas, Inc.
SIC 6798 · REAL ESTATE INVESTMENT TRUSTS
FIGI BBG001S9T7M6
XNYS · usd
92.40▲ 0.34 (0.37%)
As of 2026-07-14
Valuation
Market Cap
Enterprise Value
Trailing P/E
Price / Sales
EV / Revenue
EV / EBITDA—
Financial Highlights
Revenue (TTM)$6.1B
Net Income (TTM)$272.2M
EBITDA—
Diluted EPS (TTM)
EBITDA Margin—
Net Debt
Trading Information
Previous Close92.06
Day's Range91.81 – 92.81
52-Week Range64.72 – 94.60
Volume1.91M
Avg Volume3.85M
Share Statistics
Shares Outstanding486.2M
Employees542
ExchangeXNYS
Listed1994-10-31

Key questions about Ventas, Inc. (VTR)

What is Ventas, Inc.'s Market Cap?
Ventas, Inc.'s Market Cap is $44.9B, based on as-reported figures from SEC (XBRL) filings.
What is Ventas, Inc.'s Enterprise Value?
Ventas, Inc.'s Enterprise Value is $57.0B, based on as-reported figures from SEC (XBRL) filings.
What is Ventas, Inc.'s Trailing P/E?
Ventas, Inc.'s Trailing P/E is 165.0×, based on as-reported figures from SEC (XBRL) filings.
What is Ventas, Inc.'s Price / Sales?
Ventas, Inc.'s Price / Sales is 7.3×, based on as-reported figures from SEC (XBRL) filings.
What is Ventas, Inc.'s EV / Revenue?
Ventas, Inc.'s EV / Revenue is 9.3×, based on as-reported figures from SEC (XBRL) filings.
What is Ventas, Inc.'s Revenue (TTM)?
Ventas, Inc.'s Revenue (TTM) is $6.1B, based on as-reported figures from SEC (XBRL) filings.
What is Ventas, Inc.'s Net Income (TTM)?
Ventas, Inc.'s Net Income (TTM) is $272.2M, based on as-reported figures from SEC (XBRL) filings.
What is Ventas, Inc.'s Diluted EPS (TTM)?
Ventas, Inc.'s Diluted EPS (TTM) is 0.56, based on as-reported figures from SEC (XBRL) filings.
What is Ventas, Inc.'s Net Debt?
Ventas, Inc.'s Net Debt is $12.3B, based on as-reported figures from SEC (XBRL) filings.
Loading Income Statement…
Showing the most recent year. Subscribe for full statement history.
Income Statement(in millions of USD, except per-share data)
Source: Akyla.ai
Line ItemMar 31, 2026Dec 31, 2025Sep 30, 2025Jun 30, 2025Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022Jun 30, 2022
Rental income:
Triple-net leased properties
Outpatient medical and research portfolio
Resident fees and services——
Third-party capital management revenues
Income from loans and investments——
Interest and other income
Total revenues
YoY growth+22.0%+21.7%+20.4%+18.3%
Interest
Depreciation and amortization
Property-level operating expenses:
Senior housing—
Outpatient medical and research portfolio
Triple-net leased properties
Third-party capital management expenses—
General, administrative and professional fees
Loss on extinguishment of debt, net—
Transaction, transition and restructuring costs
Other expense——
Total expenses
% of revenue97.9%95.1%97.0%97.0%
Income before unconsolidated entities, real estate dispositions, income taxes and noncontrolling interests
Loss from unconsolidated entities
Gain on real estate dispositions
Income tax benefit
Net income
% of revenue3.6%4.7%4.6%5.0%
Net income attributable to noncontrolling interests
Net income attributable to common stockholders
Basic:
Net income————
Net income attributable to common stockholders
Diluted:
Net income————
Net income attributable to common stockholders